Using technology to find ways to measure language development in young children with Down syndrome
Leveraging technology to identify outcome measures for young children with Down syndrome
['FUNDING_R21'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-10647275
This study is looking for the best ways to track how young children with Down syndrome, ages 2 to 5, are developing their language skills, using videos recorded by their caregivers, so we can help improve their communication and support any treatments they might be receiving.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10647275 on ClinicalTrials.gov |
What this research studies
This research focuses on identifying effective outcome measures for assessing language development in young children with Down syndrome, specifically those aged 2-5 years. It aims to evaluate the feasibility and reliability of language samples collected remotely by caregivers through digital technology, such as video recordings and specialized analysis systems. By developing these measures, the research seeks to enhance the evaluation of behavioral and pharmacological interventions for this population, ultimately supporting better communication and language outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children aged 2-5 years diagnosed with Down syndrome.
Not a fit: Patients outside the age range of 2-5 years or those without a diagnosis of Down syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide reliable tools for assessing language development in young children with Down syndrome, leading to improved intervention strategies.
How similar studies have performed: Previous research has shown success in using technology for language assessment in older children, but this approach for younger children with Down syndrome is relatively novel.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STERLING, AUDRA MARIE — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: STERLING, AUDRA MARIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.